Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

±º³¯°³ Ä¡·á¸¦ À§ÇÑ ÀÚ°¡À±ºÎ°á¸·À̽ļú ÈÄ °ø¿© ºÎÀ§ÀÇ ÇÕº´Áõ ºÐ¼® Analysis of Donor-site Complications after Conjunctivo-limbal Autograft to Treat Pterygium

´ëÇѾȰúÇÐȸÁö 2019³â 60±Ç 2È£ p.109 ~ 118
Çã¹Î±¸, ¹Ú´ëÁø,
¼Ò¼Ó »ó¼¼Á¤º¸
Çã¹Î±¸ ( Huh Min-Gu ) 
´ë±¸ÆÄƼ¸¶º´¿ø ¾È°ú

¹Ú´ëÁø ( Park Dae-Jin ) 
´ë±¸ÆÄƼ¸¶º´¿ø ¾È°ú

Abstract

¸ñÀû: ¿ø¹ß ¶Ç´Â Àç¹ß ±º³¯°³ Ä¡·á¸¦ À§ÇÑ ÀÚ°¡À±ºÎ°á¸·À̽ļúÀ» ½ÃÇàÇÑ ÈÄ °ø¿© ºÎÀ§¿¡ ¹ß»ýÇÑ ÇÕº´ÁõÀÇ Á¾·ù¿Í ºóµµ, À¯¹ßÀÎÀÚµéÀ» ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.

´ë»ó°ú ¹æ¹ý: 2010³â 1¿ùºÎÅÍ 2016³â 12¿ù±îÁö º»¿ø¿¡¼­ ¿ø¹ß ¶Ç´Â Àç¹ß ±º³¯°³·Î Áø´Ü¹Þ°í ÀÚ°¡À±ºÎ°á¸·À̽ļúÀ» ½ÃÇàÇÑ ÈÄ 6°³¿ù ÀÌ»ó ÃßÀû °üÂûÀÌ °¡´ÉÇÏ¿´´ø 91¸í 91¾ÈÀ» ´ë»óÀ¸·Î, °ø¿© ºÎÀ§ÀÇ ÇÕº´Áõ ¹× À¯¹ßÀÎÀÚµéÀ» Áø·á±â·ÏÀ» ÅëÇØ ÈÄÇâÀûÀ¸·Î ºÐ¼®ÇÏ¿´´Ù.

°á°ú: 91¸í 91¾È Áß, ³²ÀÚ 37¸í 37¾È, ¿©ÀÚ 54¸í 54¾ÈÀ̾úÀ¸¸ç, Æò±Õ ³ªÀÌ´Â 53.29 ¡¾ 10.73¼¼¿´´Ù. 91¾È Áß 27¾È(29.7%)¿¡¼­ °ø¿©ºÎÀ§¿¡ °á¸·¹ÝÈçÀÌ ¹ß»ýÇÏ¿´°í, 36¾È(39.6%)¿¡¼­ ±¹¼ÒÇ÷°üÈ­°¡ ¹ß»ýÇÏ¿´´Ù. °á¸·¹ÝÈç°ú ±¹¼ÒÇ÷°üÈ­°¡ ¸ðµÎ ¹ß»ýÇß´ø °æ¿ì´Â 18¾È (19.8%)À̾ú´Ù. °á¸·À°¾ÆÁ¾°ú À±ºÎÁٱ⼼Æ÷°áÇÌÀÌ °¢°¢ 1¾È(1.1%)¿¡¼­ ¹ß»ýÇÏ¿´´Ù. ´ÙÁßȸ±ÍºÐ¼® °á°ú, °á¸·¹ÝÈç°ú ±¹¼ÒÇ÷°üÈ­ÀÇ °æ¿ì ÀþÀº ¿¬·É(p<0.001)ÀÌ Åë°èÀûÀ¸·Î À¯ÀÇÇÑ °ü·ÃÀÎÀÚ¿´À¸¸ç, ¼ºº°, ÀÏÂ÷¼º ȤÀº Àç¹ß ±º³¯°³ ¿©ºÎ, ¾È±¸°ÇÁ¶Áõ, °á¸·ÀÌ¿Ï, °íÇ÷¾Ð, ´ç´¢, Ç×ÀÀ°íÁ¦ º¹¿ë, À̽ÄÆíÀÇ Å©±â, Áö¿¬¼º »óÇÇ È¸º¹Àº À¯ÀÇÇÑ °ü°è°¡ ¾ø¾ú´Ù.

°á·Ð: ±º³¯°³ Ä¡·á¸¦ À§ÇÑ ÀÚ°¡À±ºÎ°á¸·À̽ļú ½ÃÇà ÈÄ °ø¿© ºÎÀ§¿¡ ¹ß»ýÇÑ °á¸· ¹ÝÈçÀ̳ª ±¹¼ÒÇ÷°üÈ­´Â ÀþÀº ȯÀÚ±º¿¡¼­ ºóµµ°¡ À¯ÀÇÇÏ°Ô ³ôÀº °ÍÀ¸·Î Á¶»çµÇ¾ú´Ù. µû¶ó¼­ ÀþÀº ¿¬·ÉÀÇ ±º³¯°³ ȯÀÚ¿¡¼­ ÀÚ°¡À±ºÎ°á¸·À̽ļú ½ÃÇà ½Ã °ø¿© ºÎÀ§ ÇÕº´Áõ ¹ß»ý¿¡ ´ëÇÑ ÃæºÐÇÑ ¼³¸íÀÌ ÇÊ¿äÇÒ °ÍÀ¸·Î »ý°¢µÈ´Ù.

Purpose: To evaluate the types, frequency, and causes of complications at the donor site after conjunctivo-limbal autograft for primary or recurrent pterygium treatment.

Methods: From January 2010 to December 2016, 91 eyes of 91 patients (male, n = 37; female, n = 54; mean age, 53.29 ¡¾ 10.73 years), diagnosed with primary or recurrent pterygium, and who were followed up for 6 months or longer after conjunctivo-limbal autograft, were enrolled in this study retrospectively.

Results: Of the 91 eyes, 27 eyes (29.7%) developed a conjunctival scar on the donor site and 36 eyes (39.6%) had localized vascularization. Eighteen eyes (19.8%) had a conjunctival scar and localized vascularization. Conjunctival granuloma and limbal stem cell deficiency occurred in one eye (1.1%). Multiple regression analysis showed that having a conjunctival scar and localized vascularization were significantly correlated with young age (p < 0.001), but were not significantly correlated with gender, pterygium type, dry eye, conjunctivochalasis, hypertension, diabetes, anticoagulant treatment, graft size, or delayed epithelialwound healing.

Conclusions: Conjunctival scarring or localized vascularization on the donor site after conjunctivo-limbal autograft for the treatment of the pterygium was found to be significantly higher in younger patients. Therefore, it is recommended that conjunctivo- limbal autograft should be adequately explained for donor-site complications in younger-aged pterygium patients.

Å°¿öµå

Complication; Conjunctivo-limbal autograft; Donor site; Pterygium

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS